| 000 | nam a22 7a 4500 | ||
|---|---|---|---|
| 999 |
_c72759 _d72759 |
||
| 003 | FUTML | ||
| 005 | 20251118125407.0 | ||
| 007 | TA | ||
| 008 | 251118rX X NYUa|||gr|||| 001 0 eng d | ||
| 020 | _a9781032416087 | ||
| 037 | _aB-48809 | ||
| 040 |
_aFUTML _bENG _cFUTML _dFUTML _eRDA |
||
| 050 |
_aHD30.28.R37 _b.A84 |
||
| 100 |
_aAtejevic, J. _937716 |
||
| 245 |
_aBusiness Strategy and Competitive Advantage: _bA Reinterpretation of Michael Porters work/ _cBY Jovo Ateljevic,Dzenan Kulovie,Filip Dokovic and Mirza Bavcic.- _hprint |
||
| 260 |
_aNew York: _bRouledge Taylor and Francis group, _cC 2023. |
||
| 300 |
_aXIII,179P.: _bILL.; |
||
| 504 | _aInclude only index | ||
| 590 | _aB-48809/Nana/18-11-25 | ||
| 650 |
_aBusiness Strategy _937717 |
||
| 650 |
_aCompetitive Advantage _937718 |
||
| 650 |
_aManagement _96405 |
||
| 700 |
_aKulovie, D. _937719 |
||
| 700 |
_aDokovic, F. _937720 |
||
| 700 |
_aBacic, M. _937721 |
||
| 912 |
_aNana _bNana _cDr Saba |
||
| 942 |
_2lcc _cBKS |
||
| 949 |
_aIBBL GK MX _cHD30.28.R37 _d.A84 _g2342149878 _nNC 1 2023 |
||